/
NVST
$27.02+$0.06 (+0.22%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$4.4B
163M shares
52-week range
$18.77 – $30.42
71% from low
Sector
DENTAL EQUIPMENT & SUPPLIES
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-16.75
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.84B | $2.28B | $1.93B | $2.51B | $2.57B | $2.57B | $2.51B | $2.72B |
| Cost of revenue | $1.23B | $933.1M | $856.0M | $1.05B | $1.08B | $1.12B | $1.12B | $1.22B |
| Gross profit | $1.61B | $1.35B | $1.07B | $1.46B | $1.49B | $1.45B | $1.39B | $1.50B |
| Gross margin | 56.6% | 59.2% | 55.6% | 58.3% | 57.9% | 56.5% | 55.4% | 55.0% |
| R&D | $172.0M | $133.1M | $86.7M | $100.5M | $100.1M | $93.8M | $99.1M | $114.0M |
| Operating income | $298.4M | $235.7M | $43.5M | $306.2M | $319.2M | $31.5M | −$1.04B | $225.7M |
| EBITDA | $454.8M | $377.0M | $260.2M | $496.0M | $497.7M | $463.0M | $279.5M | $329.8M |
| Net income | $230.7M | $217.6M | $33.3M | $340.5M | $243.1M | −$100.2M | −$1.12B | $47.0M |
| Net margin | 8.1% | 9.5% | 1.7% | 13.6% | 9.5% | -3.9% | -44.6% | 1.7% |
| EPS (diluted) | 1.80 | 1.35 | 0.26 | 1.48 | 1.34 | -0.60 | -6.50 | 0.28 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.9B | $1.43 | $1.40–$1.46 | 10 |
| 2027 | $3.0B | $1.57 | $1.54–$1.60 | 10 |
| 2028 | $3.1B | $1.72 | $1.20–$2.00 | 4 |
| 2029 | $3.2B | $1.91 | $1.88–$1.94 | 2 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$49.29
Price
$27.02
Implied upside
+82%
Peer comparison
Envista Holdings Corporation Common stock, $0.01 par value per share
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
www.envistaco.com- Employees
- 12,000
- IPO / List date
- Sep 18, 2019
- HQ
- BREA, CA
Held by traders on TradeandTell
No one on the platform currently holds NVST.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,208,165 | $30.7M |
| Bridgewater Associatesas of 2026-03-31 | 76,437 | $1.9M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2008-08-19 | 1-for-10reverse |
| 2006-01-12 | 1-for-300reverse |
Recent trades on TradeandTell
No one on the platform has traded NVST yet.
